Understanding the Potential Headwinds for Comerica Stock.

By Susan Ramirez • Friday, June 09 12:46 • Permanent Link

This afternoon we watched Comerica drop -4.4% to a price of $41.55 per share. The large-cap Banking company is now trading -25.82% below its average target price of $56.01. Analysts have set target prices ranging from $42.0 to $80.0 per share for Comerica, and have given the stock an average rating of buy.

Comerica has an average level of shares sold short, at 7.0% of its total share float. The stock's short ratio (also called days to cover) is 1.49. Only 0.55% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders.

Institutional investors own 84.9% of Comerica's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Comerica

Date Reported	Holder	Percentage	Shares	Value
2023-03-31	Vanguard Group, Inc. (The)	13%	17,161,267	$713,050,630
2023-03-31	Blackrock Inc.	10%	13,313,998	$553,196,606
2023-03-31	State Street Corporation	5%	6,442,220	$267,674,236
2023-03-31	First Trust Advisors LP	3%	3,878,506	$161,151,921
2023-03-31	Morgan Stanley	3%	3,457,163	$143,645,120
2023-03-31	Citadel Advisors Llc	2%	3,174,737	$131,910,319
2023-03-31	Charles Schwab Investment Management, Inc.	2%	3,020,358	$125,495,872
2023-03-31	Adage Capital Partners GP L.L.C.	2%	2,971,149	$123,451,238
2023-03-31	Geode Capital Management, LLC	2%	2,824,857	$117,372,806
2023-03-31	Alliancebernstein L.p.	2%	2,265,107	$94,115,194

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.